TB-500 and Thymosin Beta-4 are also prohibited by WADA/USADA under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), applicable at all times both in-competition and out-of-competition TB-500 / Thymosin Beta-4 Clinical Trials: The RGN-352 and RGN-259 Programs RegeneRx Biopharmaceuticals has pursued two clinical development programs for Thymosin Beta-4, providing the most substantial human clinical data available for any TB-500-related compound: RGN-352 (Injectable Thymosin Beta-4 for Cardiac Repair): Phase 1 trial (completed): A double-blind, placebo-controlled study enrolled 40 healthy volunteers across four cohorts of 10 subjects each, testing escalating dose levels of intravenous Thymosin Beta-4 administered daily over 14 days
Introduction Choosing the right supplements is only half the battle in a wellness routine
Clearly, in studies designed to establish adequate/normal serum MAA adult values, it is advisable to evaluate renal function using serum creatinine, especially in older adults
Our Over 50's IV Vitamin Drip is specifically designed to support various health functions that are crucial during this stage of life
Since 2010, weve provided the most comprehensive party product on the market